Braskem (NYSE: BAK)

$1.95-5.80%today

Brazilian ADR trading on the NYSE, priced in US dollars.

Display currency

Market Cap, EPS and the financial totals below — switch between US dollars and BRL.

Market Cap: $777.04M
P/E (TTM): —
P/B: -0.3x
EPS (TTM): $-2.67
Dividend Yield: —
52-Week Range: $1.83 – $5.39
Volume: 4.81M
Previous Close: $2.07

TTM = trailing twelve months — the most recent 12 months (a rolling window), used for P/E, EPS and dividends. On the tables and charts below, the in-progress current year appears as a “Last 12M” column labelled with the quarter range it covers.

Performance

Today

-5.80%

1 Week

-12.56%

1 Month

-20.73%

YTD

-33.90%

1 Year

-31.82%

5 Years

-90.21%

About Braskem

US Ticker: BAK
B3 Ticker: BRKM5
Exchange: NYSE
Currency: USD
Sector: Basic Materials
Industry: Chemicals
Headquarters: São Paulo, SP, Brazil
Employees: 8,233
CEO: Dr. Helcio Tokeshi
Founded: 1972

Braskem S.A., together with its subsidiaries, engages in the manufacture, sale, import, and export of chemicals, petrochemicals, and fuels in Brazil.

The company supplies electricity and other inputs to second-generation producers; sells utilities, such as steam, water, compressed air and industrial gases; industrial services; and engages in the production, supply, and sale of electric energy and gas.

It also produces and sells polyethylene, including the production of green PE made from renewable resources, and polypropylene; and polyvinyl chloride and caustic soda.

In addition, the company provides thermoplastic resins; and other basic petrochemicals.

It has operations in the United States, Europe, Asia, and internationally.

The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002.

Braskem S.A. was founded in 1972 and is headquartered in São Paulo, Brazil.

www.braskem.com.br

Analyst Ratings

Consensus of 5 Wall Street analysts · sourced from Yahoo Finance

3.2Hold

On a 1–5 scale: 1 = Strong Buy, 3 = Hold, 5 = Sell. Lower is more bullish.

12-Month Price Target

Low

$1.50

Average

$3.40

High

$6.50

The average target is +74.58% above the current price of $1.95.

Financial Results

Revenue, EBITDA and net profit (in USD) with net margin (net profit ÷ revenue).

Financial Health

Margins, leverage and cash-flow quality derived from Braskem's income statement, balance sheet and cash flow (absolute figures in USD).

ProfitabilityLeverageGrowth

Overall: Financially Stretched

Net Margin: -13.7%
ROE: 58.8%
Rev Growth (YoY): -3.73%
Net Debt / EBITDA: 8.98×
Current Ratio: 0.71×
Interest Coverage: 0.38×
Free Cash Flow: -9.20B
Payout Ratio: —

Income — Margins & Efficiency

Metric	Last 12MQ2'25 – Q1'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014	Δ	2013	Δ	2012	Δ	2011	Δ	2010	Δ	2009	Δ	2008	Δ	2007	Δ	2006
Revenue	$12,853,373,902	+1.5%	$12,659,853,913	+1.0%	$12,530,309,652	-13.9%	$14,549,709,290	-20.3%	$18,264,201,643	-3.7%	$18,962,514,811	+68.1%	$11,278,233,442	-13.4%	$13,029,703,831	-13.0%	$14,970,798,100	+0.6%	$14,877,533,146	+1.5%	$14,655,470,898	+22.6%	$11,950,108,929	-31.1%	$17,343,502,129	-0.1%	$17,365,104,056	-0.0%	$17,365,115,153	-2.4%	$17,786,918,293	+16.0%	$15,339,841,757	+75.3%	$8,748,328,170	+13.2%	$7,727,839,931	-22.7%	$10,002,796,684	+64.5%	$6,082,263,262
Gross profit	$259,205,053	-6.9%	$278,557,211	-71.3%	$970,718,205	+55.8%	$622,860,913	-71.0%	$2,149,263,899	-62.7%	$5,755,089,584	+169.2%	$2,137,582,576	+33.2%	$1,604,798,503	-46.4%	$2,992,197,357	-23.0%	$3,883,905,651	-0.7%	$3,912,114,196	+49.1%	$2,623,628,276	+16.6%	$2,250,875,250	+3.1%	$2,182,312,126	+35.1%	$1,615,294,607	-21.9%	$2,068,522,947	-15.8%	$2,456,703,971	+65.7%	$1,482,226,047	+22.2%	$1,212,865,749	-33.8%	$1,832,248,214	+77.9%	$1,030,165,618
Operating income	-$383,415,498	+46.8%	-$721,277,163	-540.3%	$163,809,709	+145.4%	-$360,809,864	-131.2%	$1,156,568,141	-76.3%	$4,879,896,593	+260.9%	$1,352,217,821	+3111.3%	$42,107,612	-98.0%	$2,143,395,540	-24.2%	$2,826,553,109	+54.5%	$1,829,857,947	+2.7%	$1,782,341,598	+32.5%	$1,344,790,324	+15.8%	$1,161,327,936	+54.4%	$752,336,316	-27.3%	$1,034,690,650	-46.5%	$1,934,392,900	+70.3%	$1,135,895,009	+121.1%	$513,769,363	-45.0%	$934,852,242	+90.2%	$491,629,812
EBITDA	$1,333,769,835	+1056.9%	$115,289,799	-73.6%	$436,394,244	-35.2%	$672,961,940	-56.1%	$1,534,269,387	-66.3%	$4,547,413,019	+132.2%	$1,958,058,225	+305.2%	$483,203,846	-79.8%	$2,392,802,385	-31.4%	$3,485,932,470	+110.1%	$1,658,893,091	-32.4%	$2,452,386,838	+21.8%	$2,013,602,728	-1.0%	$2,034,176,239	+278.7%	$537,144,394	-77.3%	$2,370,080,420	-10.3%	$2,641,548,135	+34.0%	$1,971,784,280	+605.3%	-$390,246,988	-123.5%	$1,659,027,896	+71.2%	$969,215,746
Net profit	-$1,758,588,815	+0.6%	-$1,768,731,054	+3.5%	-$1,832,337,849	-94.1%	-$944,084,780	-1384.9%	-$63,580,971	-102.5%	$2,510,681,843	+294.8%	-$1,289,140,349	-103.7%	-$632,763,414	-185.5%	$739,939,859	-40.0%	$1,233,124,943	+1074.7%	-$126,517,234	-115.9%	$793,669,219	+143.8%	$325,558,193	+50.7%	$216,037,384	+160.4%	-$357,509,657	-27.0%	-$281,547,287	-124.7%	$1,140,378,460	+116.7%	$526,235,227	+149.1%	-$1,072,332,186	-446.1%	$309,825,482	+553.3%	$47,421,356
Gross margin	2.0%	-0.2 p.p.	2.2%	-5.5 p.p.	7.7%	+3.5 p.p.	4.3%	-7.5 p.p.	11.8%	-18.6 p.p.	30.3%	+11.4 p.p.	19.0%	+6.6 p.p.	12.3%	-7.7 p.p.	20.0%	-6.1 p.p.	26.1%	-0.6 p.p.	26.7%	+4.7 p.p.	22.0%	+9.0 p.p.	13.0%	+0.4 p.p.	12.6%	+3.3 p.p.	9.3%	-2.3 p.p.	11.6%	-4.4 p.p.	16.0%	-0.9 p.p.	16.9%	+1.2 p.p.	15.7%	-2.6 p.p.	18.3%	+1.4 p.p.	16.9%
Operating margin	-3.0%	+2.7 p.p.	-5.7%	-7.0 p.p.	1.3%	+3.8 p.p.	-2.5%	-8.8 p.p.	6.3%	-19.4 p.p.	25.7%	+13.7 p.p.	12.0%	+11.7 p.p.	0.3%	-14.0 p.p.	14.3%	-4.7 p.p.	19.0%	+6.5 p.p.	12.5%	-2.4 p.p.	14.9%	+7.2 p.p.	7.8%	+1.1 p.p.	6.7%	+2.4 p.p.	4.3%	-1.5 p.p.	5.8%	-6.8 p.p.	12.6%	-0.4 p.p.	13.0%	+6.3 p.p.	6.6%	-2.7 p.p.	9.3%	+1.3 p.p.	8.1%
EBITDA margin	10.4%	+9.5 p.p.	0.9%	-2.6 p.p.	3.5%	-1.1 p.p.	4.6%	-3.8 p.p.	8.4%	-15.6 p.p.	24.0%	+6.6 p.p.	17.4%	+13.7 p.p.	3.7%	-12.3 p.p.	16.0%	-7.4 p.p.	23.4%	+12.1 p.p.	11.3%	-9.2 p.p.	20.5%	+8.9 p.p.	11.6%	-0.1 p.p.	11.7%	+8.6 p.p.	3.1%	-10.2 p.p.	13.3%	-3.9 p.p.	17.2%	-5.3 p.p.	22.5%	+27.6 p.p.	-5.0%	-21.6 p.p.	16.6%	+0.7 p.p.	15.9%
Net margin	-13.7%	+0.3 p.p.	-14.0%	+0.7 p.p.	-14.6%	-8.1 p.p.	-6.5%	-6.1 p.p.	-0.3%	-13.6 p.p.	13.2%	+24.7 p.p.	-11.4%	-6.6 p.p.	-4.9%	-9.8 p.p.	4.9%	-3.3 p.p.	8.3%	+9.2 p.p.	-0.9%	-7.5 p.p.	6.6%	+4.8 p.p.	1.9%	+0.6 p.p.	1.2%	+3.3 p.p.	-2.1%	-0.5 p.p.	-1.6%	-9.0 p.p.	7.4%	+1.4 p.p.	6.0%	+19.9 p.p.	-13.9%	-17.0 p.p.	3.1%	+2.3 p.p.	0.8%
Revenue growth (YoY)	-3.7%	+6.7 p.p.	-10.4%	-20.1 p.p.	9.7%	+36.6 p.p.	-26.9%	-18.3 p.p.	-8.6%	-89.0 p.p.	80.4%	+68.5 p.p.	11.9%	+21.7 p.p.	-9.8%	-27.5 p.p.	17.7%	+14.4 p.p.	3.4%	+2.5 p.p.	0.8%	-1.9 p.p.	2.7%	-9.6 p.p.	12.4%	-3.0 p.p.	15.4%	+8.3 p.p.	7.0%	-23.1 p.p.	30.1%	-37.1 p.p.	67.2%	+82.3 p.p.	-15.1%	-16.7 p.p.	1.6%	-34.8 p.p.	36.4%	—	—
Effective tax rate	-282.1%	+3.2 p.p.	-285.3%	-317.3 p.p.	32.0%	+11.0 p.p.	21.0%	-1825.8 p.p.	1846.8%	+1824.5 p.p.	22.3%	-5.3 p.p.	27.6%	-15.1 p.p.	42.6%	+22.2 p.p.	20.4%	-3.4 p.p.	23.9%	+463.9 p.p.	-440.0%	-476.4 p.p.	36.4%	-1.9 p.p.	38.4%	-9.0 p.p.	47.4%	+4.1 p.p.	43.3%	+2.3 p.p.	40.9%	+41.0 p.p.	-0.1%	-50.5 p.p.	50.3%	+40.1 p.p.	10.3%	-21.6 p.p.	31.8%	+46.0 p.p.	-14.2%
Interest coverage	0.38×	+155.4%	-0.68×	-248.5%	-0.19×	+52.1%	-0.41×	-140.0%	1.01×	-84.7%	6.63×	-31.9%	9.73×	+569.7%	-2.07×	-174.5%	2.78×	-23.0%	3.61×	+205.7%	1.18×	-71.3%	4.12×	+73.3%	2.38×	+4.9%	2.26×	+383.0%	-0.80×	-206.0%	0.76×	-54.0%	1.64×	-56.0%	3.73×	+196.1%	-3.88×	-212.4%	3.45×	-5.5%	3.65×

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Balance Sheet — Health & Leverage

Metric	Last 12MQ2'25 – Q1'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014	Δ	2013	Δ	2012	Δ	2011	Δ	2010	Δ	2009	Δ	2008	Δ	2007	Δ	2006
Net debt	$11,977,668,888	+7.9%	$11,099,755,305	+16.7%	$9,507,437,802	+0.9%	$9,426,827,760	+23.6%	$7,629,527,306	-5.2%	$8,052,244,623	-8.5%	$8,803,951,346	-24.5%	$11,663,159,027	+39.4%	$8,369,273,656	-11.6%	$9,469,534,898	+4.1%	$9,094,443,010	+1.9%	$8,921,300,832	-6.7%	$9,558,324,856	+14.0%	$8,386,067,478	+38.4%	$6,057,399,638	-7.4%	$6,538,823,719	+7.6%	$6,079,552,347	+49.3%	$4,071,395,869	+0.9%	$4,033,777,969	+9.8%	$3,672,984,259	+51.4%	$2,426,079,504
Net Debt / Equity	-4.00×	-6.2%	-3.77×	+72.6%	-13.73×	-198.5%	13.94×	+111.2%	6.60×	-8.7%	7.23×	+161.2%	-11.82×	-243.6%	8.23×	+50.1%	5.49×	-4.3%	5.73×	-66.7%	17.19×	-54.0%	37.33×	+767.4%	4.30×	+67.1%	2.58×	+79.9%	1.43×	+16.8%	1.23×	+26.2%	0.97×	-35.1%	1.50×	-41.3%	2.55×	+149.4%	1.02×	-14.6%	1.20×
Net Debt / EBITDA	8.98×	-90.7%	96.28×	+341.9%	21.79×	+55.5%	14.01×	+181.7%	4.97×	+180.8%	1.77×	-60.6%	4.50×	-81.4%	24.14×	+590.1%	3.50×	+28.8%	2.72×	-50.4%	5.48×	+50.7%	3.64×	-23.4%	4.75×	+15.1%	4.12×	-63.4%	11.28×	+308.8%	2.76×	+19.9%	2.30×	+11.5%	2.06×	+120.0%	-10.34×	-566.9%	2.21×	-11.6%	2.50×
Debt / Equity	-4.30×	+2.7%	-4.42×	+74.4%	-17.23×	-194.3%	18.27×	+111.4%	8.64×	+0.1%	8.63×	+156.0%	-15.40×	-273.2%	8.89×	+38.5%	6.42×	+0.1%	6.42×	-69.6%	21.08×	-52.9%	44.78×	+799.0%	4.98×	+58.6%	3.14×	+73.3%	1.81×	+18.7%	1.53×	+24.8%	1.22×	-40.6%	2.06×	-36.8%	3.26×	+147.0%	1.32×	-15.1%	1.55×
Current ratio	0.71×	-6.3%	0.76×	-42.2%	1.31×	-14.3%	1.53×	+7.3%	1.42×	-8.7%	1.56×	+29.5%	1.20×	+28.1%	0.94×	+1.6%	0.93×	-1.4%	0.94×	+33.0%	0.71×	-31.4%	1.03×	-1.9%	1.05×	-5.0%	1.10×	+10.0%	1.00×	-10.7%	1.12×	+8.2%	1.04×	+7.3%	0.97×	-5.2%	1.02×	-8.5%	1.11×	+3.1%	1.08×
Return on equity (ROE)	58.8%	-1.3 p.p.	60.0%	-204.6 p.p.	264.6%	+404.3 p.p.	-139.6%	-134.1 p.p.	-5.5%	-230.9 p.p.	225.4%	+52.4 p.p.	173.1%	+217.7 p.p.	-44.7%	-93.2 p.p.	48.5%	-26.1 p.p.	74.6%	+98.5 p.p.	-23.9%	-356.0 p.p.	332.1%	+317.5 p.p.	14.7%	+8.0 p.p.	6.6%	+15.1 p.p.	-8.5%	-3.2 p.p.	-5.3%	-23.5 p.p.	18.2%	-1.1 p.p.	19.3%	+87.1 p.p.	-67.7%	-76.3 p.p.	8.6%	+6.3 p.p.	2.3%
Return on assets (ROA)	-12.2%	-0.4 p.p.	-11.8%	-0.7 p.p.	-11.1%	-6.2 p.p.	-5.0%	-4.6 p.p.	-0.4%	-15.5 p.p.	15.1%	+22.9 p.p.	-7.8%	-3.0 p.p.	-4.8%	-9.6 p.p.	4.8%	-2.9 p.p.	7.7%	+8.5 p.p.	-0.8%	-6.0 p.p.	5.2%	+3.4 p.p.	1.7%	+0.7 p.p.	1.1%	+2.9 p.p.	-1.8%	-0.4 p.p.	-1.4%	-6.9 p.p.	5.5%	+1.3 p.p.	4.1%	+15.1 p.p.	-11.0%	-13.6 p.p.	2.6%	+2.0 p.p.	0.6%
Book value / share	$-7.51	-1.6%	$-7.39	-325.5%	$-1.74	-202.4%	$1.70	-41.5%	$2.90	+3.8%	$2.79	+249.3%	$-1.87	-152.6%	$3.56	-7.1%	$3.83	-7.7%	$4.15	+212.2%	$1.33	+121.6%	$0.60	-89.2%	$5.58	-31.8%	$8.18	-23.0%	$10.63	-20.5%	$13.37	-23.6%	$17.51	+65.7%	$10.56	+69.3%	$6.24	-62.4%	$16.61	+51.7%	$10.95

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Net Debt & Leverage

Free Cash Flow

Margins

Dividend Payout Ratio

Capex ÷ Revenue

Cash Conversion (operating cash flow ÷ net income)

Ratios computed from company financial statements. Net Debt = total debt − cash & equivalents; FCF = operating cash flow − capital expenditure; absolute values in USD.

Valuation & Dividends

Dividend History

Dividends and yield from Yahoo Finance (per ADR share, in US dollars). The current-year figures are calendar year-to-date (dividends actually paid this year), not the trailing 12 months.

Listings

Braskem trades on 4 exchanges. Prices on this page are the NYSE ADR (BAK).

Exchange	Ticker	Currency
NYSEpriced here	BAK	USD
B3 (São Paulo)	BRKM5	BRL
Latibex (Madrid)	XBRK	EUR
Mexico (BMV)	BAK	MXN

Frequently Asked Questions

Why hold Braskem BAK ADR instead of local B3 BRKM5 shares?

Buying directly on Brazil’s B3 exchange means opening a local brokerage account, converting currency and dealing with Brazilian tax paperwork. ADRs remove that friction: they settle in dollars, follow US market hours, and report in formats foreign investors already understand.

The trade-off is that an ADR’s price reflects two moving parts: (1) the underlying share price, quoted in reais on the B3, and (2) the USD/BRL exchange rate. Because of that second part, a rising company can still deliver a flat, or even negative, dollar return if the real weakens against the dollar. The same applies to ETFs: funds such as EWZ, EWZS and FLBR bundle dozens of these companies into a single ticker for instant diversification, but their dollar value still moves with the real.

Where is Braskem listed?

Braskem trades on 4 exchanges. The line quoted on this page is NYSE in the United States (BAK, US dollars). It also trades on B3 (São Paulo) in Brazil (BRKM5, Brazilian reais), Latibex (Madrid) in Spain (XBRK, euros) and Mexico (BMV) in Mexico (BAK, Mexican pesos).

On how many exchanges does Braskem trade?

4. NYSE — BAK (USD) · B3 (São Paulo) — BRKM5 (BRL) · Latibex (Madrid) — XBRK (EUR) · Mexico (BMV) — BAK (MXN). Prices shown on this page are the NYSE line, BAK.

What is Braskem's primary listing?

Braskem's primary listing is on the B3 in Brazil, where the shares trade as BRKM5 in reais — the company's home market. The NYSE line quoted on this page is an ADR over those same shares: it gives you the asset in US dollars, on US market hours, without opening a Brazilian brokerage account or trading in reais.

What is the difference between BAK and BRKM5?

They are the same company and, economically, the same asset. BRKM5 is the original Brazilian share, listed on the B3 and quoted in reais. BAK is an American Depositary Receipt over that share, listed on the NYSE and quoted in US dollars — a wrapper whose purpose is to give foreign investors access to the Brazilian asset without opening an account in Brazil. The BAK price therefore tracks two things: BRKM5 in reais, and the USD/BRL exchange rate.

How can I buy Braskem stock in Europe?

Braskem trades in euros on one European venue: Latibex (Madrid) in Spain (XBRK). A European broker with access to that market can buy it in EUR, with no currency conversion on your side. The price shown on this page is the NYSE line (BAK), quoted in US dollars.

How can I buy Braskem stock in the United States?

Braskem is listed on the NYSE under BAK, priced in US dollars. Any US brokerage offering NYSE-listed securities can trade it, with no foreign-account paperwork and no currency conversion.

As of Fri, Aug 14, 17:00 BRT · Market closed

Financial data last updated: July 17, 2026

← All stocks & ETFs